Andothelin antagonist Avosentan in patients with diabetic nepropúathy dramatically decuase proteinuria but at the expense of fluid retention. Commentary on: JASN 21,2010,527-535

Abstract

Endothelin ś antagonist, avosentan, patients with diabetics nephropathy, decuase proteinuria, retention, terminal renal failure, cardicvascular acident in patients treated with avosentan

Keywords

• Endothelin ś antagonist
• Avosentan
• patients with diabetics nephropathy
• decuase proteinuria
• retention
• terminal renal failure